NRIX insider plans Rule 144 sale of 14,261 shares

A shareholder of NRIX has filed a Rule 144 notice to sell 14,261 common shares, with an aggregate market value of $240,297.85, through Morgan Stanley Smith Barney on the NASDAQ, with an approximate sale date of 02/09/2026.

Rhea-AI Filing Summary

A shareholder of NRIX has filed a Rule 144 notice to sell 14,261 common shares, with an aggregate market value of $240,297.85, through Morgan Stanley Smith Barney on the NASDAQ, with an approximate sale date of 02/09/2026.

The shares were acquired as restricted stock units from the issuer on 05/02/2022. The filing also notes prior sales under a Rule 10b5-1 plan, including 3,760 shares sold on 01/20/2026 for $69,273.11 and 37,600 shares sold on 11/24/2025 for $641,697.02. Shares outstanding were 102,843,012 at the time referenced.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/09/2026 - 04:29 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001817199
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NURIX THERAPEUTICS, INC.
SEC File Number	001-39398
Address of Issuer	1700 Owens Street, Suite 205 San Francisco CALIFORNIA 94158
Phone	4156605320
Name of Person for Whose Account the Securities are To Be Sold	CHRISTINE RING
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	14261	240297.85	102843012	02/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/02/2022	Restricted Stock Units	Issuer			14261	05/02/2022	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CHRISTINE RING 1700 Owens Street, Suite 205 San Francisco CA 94158	Common	01/20/2026	3760	69273.11
10b5-1 Sales for CHRISTINE RING 1700 Owens Street, Suite 205 San Francisco CA 94158	Common	12/18/2025	3760	67314.15
10b5-1 Sales for CHRISTINE RING 1700 Owens Street, Suite 205 San Francisco CA 94158	Common	11/24/2025	37600	641697.02

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 5/02/2022 through 1/30/2026.
Date of Notice	02/09/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Christine Ring
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)